A Collaborative Intervention Between Emergency Medicine and Infectious Diseases to Increase Syphilis and HIV Screening in the Emergency Department.

Autor:	Lipps AA; From the Division of Infectious Diseases, The Ohio State University College of Medicine., Bazan JA, Lustberg ME; From the Division of Infectious Diseases, The Ohio State University College of Medicine., Sobhanie MM; From the Division of Infectious Diseases, The Ohio State University College of Medicine., Pollak B; Division of General Internal Medicine., Nandam K; Department of Emergency Medicine, The Ohio State University College of Medicine, Columbus, OH., Koletar SL; From the Division of Infectious Diseases, The Ohio State University College of Medicine., Lindsey S; Department of Emergency Medicine, The Ohio State University College of Medicine, Columbus, OH., Dick M; Department of Emergency Medicine, The Ohio State University College of Medicine, Columbus, OH., Malvestutto C; From the Division of Infectious Diseases, The Ohio State University College of Medicine.
Jazyk:	angličtina
Zdroj:	Sexually transmitted diseases [Sex Transm Dis] 2022 Jan 01; Vol. 49 (1), pp. 50-54.
DOI:	10.1097/OLQ.0000000000001496
Abstrakt:	Background: Sexually transmitted infections (STIs) are a common reason for evaluation in the emergency department (ED). Given the overlapping risk factors for STIs, patients screened for gonorrhea and chlamydia should be tested for syphilis and HIV. Syphilis and HIV testing rates in the ED have been reported to be low. The study objective was to examine whether collaboration between emergency medicine (EM) and infectious disease (ID) providers improved syphilis and HIV testing in the ED. Methods: A multidisciplinary team of EM and ID providers was formed to identify and address barriers to syphilis and HIV testing in the ED. Syphilis, HIV, chlamydia, and gonorrhea testing and infection rates were calculated and compared during 2 time periods: preintervention (January 1, 2012-December 30, 2017) and postintervention (November 1, 2018-November 30, 2019). We also extracted clinical and laboratory data from patients with positive syphilis and HIV results during the study period. Results: The most commonly cited barrier to syphilis and HIV testing was concern about follow-up of positive results. Compared with the preintervention period, syphilis and HIV testing rates increased significantly in the postintervention period (incidence rate ratios, 30.70 [P < 0.0001] and 28.99 [P < 0.0001] for syphilis and HIV, respectively). The postintervention period was also associated with a significant increase in the identification of patients with positive syphilis and HIV results (incidence rate ratios, 7.02 [P < 0.0001] and 2.34 [P = 0.03], respectively). Conclusions: Collaboration between EM and ID providers resulted in a significant increase in syphilis and HIV testing and diagnosis in the ED. Competing Interests: Conflict of Interest and Sources of Funding: The authors have no relevant disclosures. This work has received The Ohio State University Wexner Medical Center Patient Care Innovation Award (principal awardee: C.M.). (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu